6,42 $
2,56 %heute
Nasdaq, 29. Februar, 15:13 Uhr
ISIN
IL0010941198
Symbol
KMDA
Berichte
Sektor
Industrie

Kamada Ltd Aktie News

Neutral
GlobeNewsWire
ein Tag alt
REHOVOT, Israel, and HOBOKEN, N.J., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Kamada Ltd.
Positiv
Seeking Alpha
3 Monate alt
Kamada is a profitable specialty plasma company with a strong balance sheet and significant capital available for investment. The company has announced an expanded commercial agreement for its anti-rabies drug Kedrab including a minimum revenue guarantee for the next four years. The new deal significantly derisks the Kamada investment case by locking in growth for one of the company's largest r...
Neutral
MCAP MediaWire
3 Monate alt
NEW YORK, NY, December 07, 2023 – PRISM MarketView, a leading provider of unbiased market insight and company news, highlights Kamada Ltd.
Neutral
PRNewsWire
3 Monate alt
Since 2018 Kedrion has had exclusive distribution rights in the US for KEDRAB®, a Human Rabies Immune Globulin (HRIG) developed in partnership with Kamada Ltd. New agreement becomes effective in January 2024 and includes potential expansion of Kedrion's distribution of KEDRAB® in additional territories beyond the US Rabies is a global public health concern that is responsible for more than 59,0...
Neutral
GlobeNewsWire
3 Monate alt
REHOVOT, Israel and HOBOKEN, N.J., Dec. 06, 2023 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a commercial stage global biopharmaceutical company with a portfolio of marketed products indicated for rare and serious conditions and a leader in the specialty plasma-derived field, today announced the execution of a binding memorandum of understanding with Kedrion for the amendment...
Positiv
Seeking Alpha
3 Monate alt
In November, we welcomed 24 new analysts who published their first article on Seeking Alpha. This series highlights and welcomes these newcomers to our ranks of analysts who share their unique insights and perspectives as well as some of their top investing ideas. We've compiled all of their firsts here for your review and to showcase the new perspectives being offered on the platform.
Positiv
Seeking Alpha
3 Monate alt
Kamada is a profitable specialty plasma company with a strong balance sheet and significant capital available for investment. The company is expected to grow EBITDA significantly in the coming years through its existing business and potential acquisitions or licensing of new products. Limited downside outside Israel country risk.
Neutral
Seeking Alpha
4 Monate alt
Kamada Ltd. (NASDAQ:KMDA ) Q3 2023 Earnings Conference Call November 13, 2023 8:30 AM ET Company Participants Brian Ritchie - IR, LifeSci Advisors Amir London - Chief Executive Officer Chaime Orlev - Chief Financial Officer Conference Call Participants Annabel Samimy - Stifel Operator Good day ladies and gentlemen and welcome to Kamada Ltd.

Kostenlos registrieren

aktien.guide ist das Tool zum einfachen Finden, Analysieren und Beobachten von Aktien. Lerne von erfolgreichen Investoren und triff fundierte Anlageentscheidungen. Wir machen Dich zum selbstbestimmten Investor.

Die Apple Aktie im Überblick mit Charts, aktuellen Kennzahlen, Nachrichten und Aktienanalysen.
Die besten Dividenden-Aktien in der Dividenden-Topscorer-Liste.
Aktienanalysen der besten Aktien weltweit.
Jetzt Vermögen aufbauen